SARTORIUS STEDIM BIOTECH (DIM.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:DIM - FR0013154002 - Common Stock
207.9 EUR
+2 (+0.97%)
Overall DIM gets a fundamental rating of 4 out of 10. We evaluated DIM against 19 industry peers in the Life Sciences Tools & Services industry. DIM has only an average score on both its financial health and profitability. DIM shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
DIM had positive earnings in the past year.
In the past year DIM had a positive cash flow from operations.
Each year in the past 5 years DIM has been profitable.
Each year in the past 5 years DIM had a positive operating cash flow.
1.2 Ratios
The Return On Assets of DIM (3.35%) is worse than 63.16% of its industry peers.
DIM has a Return On Equity (6.54%) which is in line with its industry peers.
DIM has a Return On Invested Capital (5.94%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for DIM is in line with the industry average of 9.26%.
The last Return On Invested Capital (5.94%) for DIM is well below the 3 year average (10.41%), which needs to be investigated, but indicates that DIM had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.35% | ||
| ROE | 6.54% | ||
| ROIC | 5.94% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
1.3 Margins
DIM has a Profit Margin (8.96%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of DIM has declined.
The Operating Margin of DIM (16.63%) is better than 63.16% of its industry peers.
In the last couple of years the Operating Margin of DIM has declined.
DIM's Gross Margin of 45.64% is fine compared to the rest of the industry. DIM outperforms 68.42% of its industry peers.
DIM's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.63% | ||
| PM (TTM) | 8.96% | ||
| GM | 45.64% |
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DIM is creating some value.
DIM has more shares outstanding than it did 1 year ago.
DIM has more shares outstanding than it did 5 years ago.
DIM has a better debt/assets ratio than last year.
2.2 Solvency
DIM has an Altman-Z score of 4.43. This indicates that DIM is financially healthy and has little risk of bankruptcy at the moment.
DIM has a better Altman-Z score (4.43) than 84.21% of its industry peers.
DIM has a debt to FCF ratio of 6.84. This is a slightly negative value and a sign of low solvency as DIM would need 6.84 years to pay back of all of its debts.
DIM has a Debt to FCF ratio (6.84) which is in line with its industry peers.
A Debt/Equity ratio of 0.50 indicates that DIM is not too dependend on debt financing.
DIM has a Debt to Equity ratio (0.50) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 6.84 | ||
| Altman-Z | 4.43 |
ROIC/WACC0.64
WACC9.26%
2.3 Liquidity
A Current Ratio of 1.05 indicates that DIM should not have too much problems paying its short term obligations.
DIM has a Current ratio of 1.05. This is in the lower half of the industry: DIM underperforms 68.42% of its industry peers.
DIM has a Quick Ratio of 1.05. This is a bad value and indicates that DIM is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DIM (0.50) is worse than 78.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.5 |
3. Growth
3.1 Past
DIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.11%, which is quite impressive.
The Earnings Per Share has been growing slightly by 4.19% on average over the past years.
Looking at the last year, DIM shows a small growth in Revenue. The Revenue has grown by 7.72% in the last year.
DIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.05% yearly.
EPS 1Y (TTM)35.11%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%23.68%
Revenue 1Y (TTM)7.72%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%7.67%
3.2 Future
The Earnings Per Share is expected to grow by 22.11% on average over the next years. This is a very strong growth
Based on estimates for the next years, DIM will show a quite strong growth in Revenue. The Revenue will grow by 10.12% on average per year.
EPS Next Y29.39%
EPS Next 2Y23.86%
EPS Next 3Y23.06%
EPS Next 5Y22.11%
Revenue Next Year7.45%
Revenue Next 2Y8.04%
Revenue Next 3Y9.07%
Revenue Next 5Y10.12%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
DIM is valuated quite expensively with a Price/Earnings ratio of 48.24.
Based on the Price/Earnings ratio, DIM is valued a bit more expensive than 78.95% of the companies in the same industry.
DIM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.92.
The Price/Forward Earnings ratio is 38.72, which means the current valuation is very expensive for DIM.
Based on the Price/Forward Earnings ratio, DIM is valued a bit more expensive than 78.95% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of DIM to the average of the S&P500 Index (23.46), we can say DIM is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.24 | ||
| Fwd PE | 38.72 |
4.2 Price Multiples
84.21% of the companies in the same industry are cheaper than DIM, based on the Enterprise Value to EBITDA ratio.
DIM's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 54.03 | ||
| EV/EBITDA | 27.62 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as DIM's earnings are expected to grow with 23.06% in the coming years.
PEG (NY)1.64
PEG (5Y)11.5
EPS Next 2Y23.86%
EPS Next 3Y23.06%
5. Dividend
5.1 Amount
DIM has a yearly dividend return of 0.34%, which is pretty low.
DIM's Dividend Yield is slightly below the industry average, which is at 0.60.
Compared to an average S&P500 Dividend Yield of 2.00, DIM's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.34% |
5.2 History
The dividend of DIM has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
DIM pays out 25.41% of its income as dividend. This is a sustainable payout ratio.
DIM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP25.41%
EPS Next 2Y23.86%
EPS Next 3Y23.06%
EPA:DIM (12/29/2025, 4:16:10 PM)
207.9
+2 (+0.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners11.74%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.23B
Revenue(TTM)2.95B
Net Income(TTM)264.10M
Analysts81.11
Price Target245.19 (17.94%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.34% |
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP25.41%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.99%
Min EPS beat(2)-2.24%
Max EPS beat(2)10.22%
EPS beat(4)3
Avg EPS beat(4)9.45%
Min EPS beat(4)-2.24%
Max EPS beat(4)22.18%
EPS beat(8)3
Avg EPS beat(8)-1.58%
EPS beat(12)3
Avg EPS beat(12)-11.08%
EPS beat(16)4
Avg EPS beat(16)-13.1%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-3.94%
Max Revenue beat(2)0.3%
Revenue beat(4)3
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-3.94%
Max Revenue beat(4)3.52%
Revenue beat(8)5
Avg Revenue beat(8)-0.23%
Revenue beat(12)5
Avg Revenue beat(12)-1.54%
Revenue beat(16)7
Avg Revenue beat(16)-0.72%
PT rev (1m)2.66%
PT rev (3m)2.43%
EPS NQ rev (1m)4.24%
EPS NQ rev (3m)14.4%
EPS NY rev (1m)0.86%
EPS NY rev (3m)1.39%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-1.38%
Revenue NY rev (3m)-2.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.24 | ||
| Fwd PE | 38.72 | ||
| P/S | 6.87 | ||
| P/FCF | 54.03 | ||
| P/OCF | 27.7 | ||
| P/B | 5.01 | ||
| P/tB | N/A | ||
| EV/EBITDA | 27.62 |
EPS(TTM)4.31
EY2.07%
EPS(NY)5.37
Fwd EY2.58%
FCF(TTM)3.85
FCFY1.85%
OCF(TTM)7.51
OCFY3.61%
SpS30.27
BVpS41.47
TBVpS-4.02
PEG (NY)1.64
PEG (5Y)11.5
Graham Number63.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.35% | ||
| ROE | 6.54% | ||
| ROCE | 7.46% | ||
| ROIC | 5.94% | ||
| ROICexc | 6.26% | ||
| ROICexgc | 21.64% | ||
| OM | 16.63% | ||
| PM (TTM) | 8.96% | ||
| GM | 45.64% | ||
| FCFM | 12.71% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexgc growth 3Y-36.77%
ROICexgc growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score8
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 6.84 | ||
| Debt/EBITDA | 2.5 | ||
| Cap/Depr | 113.12% | ||
| Cap/Sales | 12.09% | ||
| Interest Coverage | 3.09 | ||
| Cash Conversion | 90.78% | ||
| Profit Quality | 141.8% | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.5 | ||
| Altman-Z | 4.43 |
F-Score8
WACC9.26%
ROIC/WACC0.64
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)35.11%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%23.68%
EPS Next Y29.39%
EPS Next 2Y23.86%
EPS Next 3Y23.06%
EPS Next 5Y22.11%
Revenue 1Y (TTM)7.72%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%7.67%
Revenue Next Year7.45%
Revenue Next 2Y8.04%
Revenue Next 3Y9.07%
Revenue Next 5Y10.12%
EBIT growth 1Y25.54%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year93.64%
EBIT Next 3Y36.06%
EBIT Next 5Y27.7%
FCF growth 1Y219.27%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y15.97%
OCF growth 3Y5.11%
OCF growth 5Y21.32%
SARTORIUS STEDIM BIOTECH / DIM.PA FAQ
What is the fundamental rating for DIM stock?
ChartMill assigns a fundamental rating of 5 / 10 to DIM.PA.
What is the valuation status for DIM stock?
ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS STEDIM BIOTECH (DIM.PA). This can be considered as Overvalued.
What is the profitability of DIM stock?
SARTORIUS STEDIM BIOTECH (DIM.PA) has a profitability rating of 5 / 10.
How financially healthy is SARTORIUS STEDIM BIOTECH?
The financial health rating of SARTORIUS STEDIM BIOTECH (DIM.PA) is 4 / 10.
How sustainable is the dividend of SARTORIUS STEDIM BIOTECH (DIM.PA) stock?
The dividend rating of SARTORIUS STEDIM BIOTECH (DIM.PA) is 4 / 10 and the dividend payout ratio is 25.41%.